Cite

    J S Smolen et al.. “060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate.” Rheumatology, vol. 58, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100092358787.0x000021